Patient Management

2074 questions

Question 101Question →

A 52-year-old woman is brought to the emergency department due to sudden-onset, severe abdominal pain and bilious vomiting that started 12 hours ago. She reports no bowel movements or flatus during this time. Her medical history is unremarkable, and she has had no prior abdominal surgeries. Her temperature is 37.6∘C37.6^\circ\text{C} (99.7∘F99.7^\circ\text{F}), blood pressure is 115/75 mmHg115/75\text{ mmHg}, and heart rate is 110/min110/\text{min}. Physical examination reveals an asymmetric, tympanic, and markedly distended abdomen. There is diffuse tenderness to palpation but no guarding or rigidity. Laboratory results are notable for a leukocyte count of 12,500/mm312,500/\text{mm}^3 and a normal serum lactate level. A CT scan of the abdomen with intravenous contrast demonstrates a severely dilated cecum measuring 10.5 cm10.5\text{ cm} in diameter displaced into the left upper quadrant, with a "whirl pattern" of the mesenteric vessels and collapsed distal bowel. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Urgent exploratory laparotomy

Answer

Urgent exploratory laparotomy is required for the treatment of a cecal volvulus to prevent bowel ischemia and perforation.
The clinical presentation and CT findings (a markedly dilated cecum displaced to the left upper quadrant and a 'whirl pattern' of the mesentery) are diagnostic of a cecal volvulus. Because a cecal volvulus represents a closed-loop mechanical obstruction involving a twist of the ascending colon, it carries an exceptionally high risk of rapid vascular compromise, gangrene, and perforation. The standard of care is urgent surgical intervention, typically an exploratory laparotomy with right colectomy or cecopexy. Non-operative management is associated with high failure rates and unacceptable morbidity in these patients.

Step-by-Step Solution

1
Analyze the clinical presentation and radiographic findings.
The patient presents with signs of an acute mechanical bowel obstruction. The CT scan showing a dilated cecum in the left upper quadrant with a mesenteric 'whirl pattern' is diagnostic of a cecal volvulus.
Accurate interpretation of imaging prevents misdiagnosing the condition as a sigmoid volvulus or an adynamic ileus.
2
Determine the pathophysiological risk of the diagnosed condition.
A cecal volvulus is a closed-loop obstruction involving a twist of the ascending colon and terminal ileum, carrying a high risk of vascular compromise and perforation.
Understanding the high risk of rapid progression to gangrene dictates the urgency and modality of the intervention.
3
Select the most appropriate evidence-based intervention.
Urgent exploratory laparotomy is chosen as the definitive treatment.
Unlike sigmoid volvulus, cecal volvulus cannot be safely or effectively managed with endoscopic decompression, making immediate surgery the standard of care.

Key Concept

Cecal volvulus is a closed-loop surgical emergency that requires immediate operative intervention (exploratory laparotomy), in contrast to sigmoid volvulus, which can often be initially managed with endoscopic decompression.
Question 102Question →

An asymptomatic 68-year-old retired teacher presents for an annual wellness assessment. He reports feeling well with no active complaints. His past medical history includes well-controlled essential hypertension and hyperlipidemia. He has a 40 pack-year smoking history but successfully quit 8 years ago. He consumes alcohol occasionally and walks briskly for 30 minutes three times a week.

His immunization history shows a tetanus, diphtheria, and acellular pertussis (Tdap) booster 3 years ago, completion of the two-dose recombinant zoster vaccine series at age 65, and a recent annual influenza vaccination. He has no history of receiving any pneumococcal vaccines. A screening colonoscopy performed 5 years ago was entirely normal. Physical examination today reveals a blood pressure of 126/78 mmHg, a heart rate of 72/min, and a body mass index of 27 kg/m².

Which of the following interventions are indicated for this patient at this visit? (Select all that apply)

Select all that apply

Show answer & explanation

Answer: Administration of the 20-valent pneumococcal conjugate vaccine; Annual screening for lung cancer with low-dose computed tomography; One-time screening for abdominal aortic aneurysm with ultrasonography

Answer

The indicated interventions are the administration of the 20-valent pneumococcal conjugate vaccine, annual screening for lung cancer with low-dose computed tomography, and a one-time screening for abdominal aortic aneurysm with ultrasonography.
Based on current preventive care guidelines, this 68-year-old former smoker requires three specific interventions. First, as a man aged 65 to 75 who has ever smoked, he meets the criteria for a one-time screening for abdominal aortic aneurysm with ultrasonography. Second, because he is between 50 and 80 years old, has a smoking history of at least 20 pack-years, and quit less than 15 years ago, he requires annual lung cancer screening with low-dose CT. Third, as an adult over 65 who has never received pneumococcal immunization, he should receive the 20-valent pneumococcal conjugate vaccine (or PCV15 followed by PPSV23).

Step-by-Step Solution

1
Evaluate the patient's age and vaccination history.
The patient is 68 years old and has never received a pneumococcal vaccine.
Current ACIP guidelines recommend pneumococcal vaccination for all adults aged 65 and older.
2
Assess the patient's smoking history against age-specific screening guidelines.
The patient is a 68-year-old male with a 40 pack-year smoking history who quit 8 years ago.
This qualifies him for both annual lung cancer screening (indicated for ages 50-80, ≥20 pack-years, quit within 15 years) and a one-time abdominal aortic aneurysm screening (indicated for men ages 65-75 who have ever smoked).
3
Review the clinical indications for cardiovascular and carotid screening in asymptomatic patients.
The patient is asymptomatic with no history of transient ischemic attack or cardiovascular symptoms.
Routine screening for carotid artery stenosis and coronary artery disease using ECG in asymptomatic adults is not recommended and can lead to unnecessary downstream testing.

Key Concept

Evidence-Based Preventive Care and Screening in Older Adults
Question 103Question →

A 6262-year-old woman is evaluated in the hospital for new-onset right leg swelling and pain. She was admitted 66 days ago for an acute pulmonary embolism and was subsequently started on a continuous unfractionated heparin infusion. On admission, her platelet count was 260,000/mm3260,000/\text{mm}^3. Today, her vital signs are temperature 37.1∘C37.1^\circ\text{C} (98.8∘F98.8^\circ\text{F}), blood pressure 130/80 mmHg130/80\text{ mmHg}, pulse 92/min92/\text{min}, and respirations 16/min16/\text{min}. Physical examination reveals a visibly swollen right calf that is tender to palpation. A venous Doppler ultrasound of the right lower extremity demonstrates an acute deep venous thrombosis in the right femoral vein. Laboratory studies from this morning show a platelet count of 110,000/mm3110,000/\text{mm}^3 and an activated partial thromboplastin time (aPTT) of 65 seconds65\text{ seconds} (therapeutic range: 60−80 seconds60-80\text{ seconds}). Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Discontinue unfractionated heparin and start an argatroban infusion

Answer

Discontinue unfractionated heparin and start an argatroban infusion
The correct action is to immediately discontinue all heparin products and begin alternative anticoagulation with a direct thrombin inhibitor, such as argatroban. This patient presents with a classic picture of Type II Heparin-Induced Thrombocytopenia (HIT). The diagnosis is heavily supported by her clinical presentation: a platelet count drop of greater than 50%50\% from baseline, an onset precisely 55 to 1010 days after heparin initiation, and the development of a new thrombotic complication (deep venous thrombosis) while on therapy. These factors yield a high probability '4Ts' score. Because HIT is an intensely prothrombotic state driven by IgG antibodies against the heparin-PF4 complex, all heparin exposure must be eliminated instantly. To protect against life-threatening thromboses, an alternative non-heparin anticoagulant must be instituted immediately.

Step-by-Step Solution

1
Evaluate the clinical criteria for Heparin-Induced Thrombocytopenia (HIT) using the 4Ts score.
The patient has a platelet drop of >50% (Thrombocytopenia = 2 points), onset 6 days after heparin initiation (Timing = 2 points), and a new deep venous thrombosis (Thrombosis = 2 points), indicating a high probability of HIT.
Accurate calculation of the 4Ts score determines whether immediate intervention for HIT is necessary before confirmatory labs result.
2
Determine the immediate intervention required for suspected HIT.
All forms of heparin must be discontinued instantly.
Continuing heparin or switching to closely related drugs will worsen the immune-mediated platelet activation and thrombosis.
3
Select the appropriate alternative anticoagulation therapy.
A non-heparin anticoagulant, such as a direct thrombin inhibitor (argatroban, bivalirudin) or fondaparinux, must be initiated.
The patient remains in a highly hypercoagulable state and requires immediate, safe anticoagulation to treat both the original pulmonary embolism and the new deep venous thrombosis.

Key Concept

Diagnosis and management of Heparin-Induced Thrombocytopenia (HIT)
Question 104Question →

A 4545-year-old man presents to the clinic for a routine 44-week follow-up visit. One month ago, he was diagnosed with active pulmonary tuberculosis and was started on a daily regimen of isoniazid, rifampin, pyrazinamide, and ethambutol, supplemented with pyridoxine. Today, he reports significant improvement in his symptoms; his cough has nearly resolved, and his night sweats have ceased. He has a good appetite and explicitly denies any nausea, vomiting, abdominal pain, fatigue, or dark urine. Physical examination reveals normal vital signs, no scleral icterus, and a non-tender abdomen without hepatomegaly.

Laboratory studies obtained today show the following:

Total bilirubin: 0.8 mg/dL0.8 \text{ mg/dL} (Reference: 0.1−1.2 mg/dL0.1-1.2 \text{ mg/dL})
Alkaline phosphatase: 85 U/L85 \text{ U/L} (Reference: 40−120 U/L40-120 \text{ U/L})
Aspartate aminotransferase (AST): 165 U/L165 \text{ U/L} (Reference: 10−40 U/L10-40 \text{ U/L})
Alanine aminotransferase (ALT): 175 U/L175 \text{ U/L} (Reference: 10−40 U/L10-40 \text{ U/L})

Which of the following is the most appropriate next step in the monitoring and management of this patient?

Show answer & explanation

Answer: Continue the current medication regimen and repeat liver chemistries in 1 to 2 weeks.

Answer

Continue the current medication regimen and repeat liver chemistries in 1 to 2 weeks.
The correct answer involves continuing the current anti-tuberculosis therapy while scheduling close laboratory follow-up. Isoniazid, rifampin, and pyrazinamide are known to be hepatotoxic and frequently cause a transient, asymptomatic elevation in hepatic transaminases (AST and ALT) during the initial weeks of treatment. According to established guidelines, hepatotoxic anti-tuberculosis drugs should be discontinued only if serum transaminases exceed 33 times the upper limit of normal (ULN) in the presence of symptoms (e.g., nausea, vomiting, abdominal pain, jaundice), or if they exceed 55 times the ULN in an asymptomatic patient. This patient's transaminases are elevated to approximately 44 times the ULN (e.g., 175 U/L175 \text{ U/L} versus the normal upper limit of 40 U/L40 \text{ U/L}), but he remains completely asymptomatic. Therefore, the threshold for medication discontinuation has not been met. The most appropriate management is to maintain the current regimen and monitor liver function tests closely (e.g., in 11 to 22 weeks) to ensure the transaminases do not cross the critical threshold.

Step-by-Step Solution

1
Identify the clinical scenario.
An asymptomatic patient on a standard 4-drug regimen for tuberculosis presents with elevated hepatic transaminases at a 4-week follow-up.
Establishing the patient's symptom status (asymptomatic) and current medications (hepatotoxic agents) is critical for applying the correct monitoring algorithm.
2
Calculate the magnitude of transaminase elevation.
AST is 165 U/L and ALT is 175 U/L. Given an upper limit of normal (ULN) of 40 U/L, the elevation is approximately 4.1 to 4.3 times the ULN.
Guidelines for drug-induced hepatotoxicity rely on precise multipliers of the upper limit of normal to dictate management.
3
Apply the clinical guidelines for anti-tuberculosis drug-induced hepatotoxicity.
Guidelines dictate holding hepatotoxic drugs if transaminases are >3 times the ULN in symptomatic patients, or >5 times the ULN in asymptomatic patients.
This standardized rule prevents premature discontinuation of life-saving therapy while ensuring patient safety from irreversible liver damage.
4
Determine the appropriate monitoring action.
Because the patient is asymptomatic and the transaminases are <5 times the ULN, the correct action is to continue therapy and perform close serial monitoring.
Continuing therapy balances the need for bacterial eradication with the observation of a frequently transient laboratory abnormality.

Key Concept

Monitoring guidelines for anti-tuberculosis drug-induced hepatotoxicity
Estimated Time:1m 30s
Question 105Question →

A 79-year-old man is admitted to the intensive care unit with severe septic shock and multiorgan failure. He is currently intubated, sedated, and lacks clinical decision-making capacity. The medical team concludes that further aggressive interventions are futile and wishes to discuss transitioning to comfort-focused care. A chart review reveals no advance directive, living will, or designated durable power of attorney for healthcare. The patient is a widower and his parents are deceased. He is survived by an adult son who lives in another state, a brother who visits him daily, and a devoted neighbor who has served as his primary caregiver for the past three years. Which of the following individuals is the most appropriate legally recognized primary surrogate decision-maker for this patient?

Show answer & explanation

Answer: The adult son

Answer

The adult son
In the absence of an advance directive or designated healthcare proxy, medical decisions for an incapacitated patient must be made by a surrogate decision-maker based on a legal hierarchy. While minor variations exist between states, the standard hierarchy universally prioritizes spouses, followed by adult children, parents, and then adult siblings. Because this patient is a widower and his parents are deceased, his adult son is the highest-ranking legal surrogate. The geographical distance of the son or the daily involvement of the brother and neighbor does not alter the legal priority.

Step-by-Step Solution

1
Determine the patient's clinical capacity and the presence of an advance directive.
The patient lacks clinical capacity and has no advance directive or designated proxy.
This establishes the legal requirement to identify a surrogate decision-maker.
2
Apply the standard legal hierarchy for surrogate decision-makers.
The hierarchy prioritizes the spouse, followed by adult children, parents, and then adult siblings.
To identify the highest-ranking legally authorized individual to make medical decisions.
3
Evaluate the available individuals against the legal hierarchy.
The adult son is the highest-ranking available surrogate, outranking the brother and the neighbor.
Geographical distance and caregiver involvement do not supersede the established legal hierarchy order.

Key Concept

In the absence of an advance directive, medical decision-making defaults to a legal surrogate hierarchy, which universally prioritizes adult children over adult siblings and friends.
Question 106Question →

A 32-year-old nulliparous woman arrives at the outpatient clinic to establish primary care. She reports excellent overall health and exercises regularly. She has no gastrointestinal complaints, unexplained weight changes, or evidence of bleeding. Her medical background is notable only for an appendectomy during childhood. Family history is significant for her mother, who was diagnosed with an early-stage colonic adenocarcinoma at the age of 46 and underwent a curative hemicolectomy. Medical records confirm the mother's tumor underwent mismatch repair protein analysis, demonstrating no loss of nuclear expression. Her maternal grandfather developed a similar intestinal malignancy at the age of 72. The patient expresses anxiety regarding her familial susceptibility and inquires about the optimal timing and modality for her own surveillance. Based on current evidence-based guidelines, which of the following is the most appropriate strategy for this patient?

Show answer & explanation

Answer: Initiate colonoscopic evaluation at age 36, with subsequent examinations every 5 years

Answer

Initiate colonoscopic evaluation at age 36, with subsequent examinations every 5 years
The patient is at increased risk for colorectal cancer due to a first-degree relative (her mother) diagnosed before age 60. According to the US Multi-Society Task Force on Colorectal Cancer, individuals with this family history must begin screening at age 40, OR 10 years earlier than the youngest age of diagnosis in the family, whichever comes first. Since the mother was diagnosed at age 46, this patient must begin screening at age 36 (10 years earlier), as it is sooner than age 40. For high-risk individuals, the only appropriate modality is direct structural visualization via colonoscopy, and the required surveillance interval is every 5 years if the initial exam is normal. Furthermore, the mother's intact mismatch repair proteins lower the clinical suspicion for Lynch syndrome, confirming that earlier empirical screening (e.g., immediately at age 32) is not indicated.

Step-by-Step Solution

1
Assess the patient's colorectal cancer risk level based on family history.
High risk due to a first-degree relative (mother) diagnosed at age < 60.
Family history dictates the starting age, screening modality, and surveillance frequency.
2
Determine the appropriate starting age for high-risk screening.
Start at age 36. The rule is age 40 OR 10 years prior to the relative's diagnosis, whichever is earlier. Mother's diagnosis at 46 minus 10 equals 36.
Applying the exact US Multi-Society Task Force guidelines for high-risk familial CRC ensures timely detection.
3
Determine the appropriate modality and surveillance interval.
Colonoscopy every 5 years.
High-risk patients require structural exams (colonoscopy); non-invasive stool tests are inadequate. The high-risk interval is 5 years.
4
Rule out the immediate need for hereditary cancer syndrome screening.
The mother's normal mismatch repair analysis makes Lynch syndrome unlikely, so screening does not need to start immediately at age 32.
Ensures premature invasive testing is avoided while adhering strictly to empirical family history algorithms.

Key Concept

Patients with a first-degree relative diagnosed with colorectal cancer before age 60 require screening colonoscopy starting at age 40 or 10 years before the relative's diagnosis (whichever is earlier), repeated every 5 years.
Question 107Question →

A 42-year-old man comes to the clinic for a routine follow-up visit. He was diagnosed with hypertension and type 2 diabetes mellitus three months ago, at which time he was prescribed amlodipine and metformin. Today, his blood pressure is 154/92 mmHg and his hemoglobin A1c is 8.5%. Upon inquiry, the patient admits he stopped taking both medications after one week. He explains, "A coworker warned me that these blood pressure pills will eventually destroy my kidneys. I started taking a daily herbal detox supplement instead. I feel perfectly fine, so I do not want to put unnatural chemicals into my body." Which of the following is the most appropriate initial response by the physician?

Show answer & explanation

Answer: It sounds like you are making a conscious effort to protect your health. Can you share more about your specific concerns regarding these prescription medications?

Answer

The most appropriate response is to validate the patient's intent to protect their health and openly explore their specific concerns about the medications.
The correct answer demonstrates the fundamental principles of effective patient counseling and motivational interviewing. When a patient exhibits nonadherence due to health beliefs or misinformation, the most effective initial strategy is to validate their underlying intent (in this case, protecting their health) and non-judgmentally explore their concerns. This approach builds a strong therapeutic alliance and provides the physician with the specific context needed to offer targeted, personalized health education later in the encounter.

Step-by-Step Solution

1
Identify the core clinical issue presenting in the encounter.
The patient is nonadherent to critical chronic disease medications due to health misinformation and a preference for alternative supplements.
Recognizing the barrier to adherence determines the counseling approach.
2
Evaluate the patient's emotional state and underlying motivations.
The patient believes they are actively protecting their kidneys by avoiding 'unnatural chemicals'.
Understanding the patient's motivation allows the physician to reframe the conversation collaboratively rather than confrontationally.
3
Determine the most effective communication strategy based on motivational interviewing principles.
The physician must first build rapport, validate the patient's positive intent, and explore their perspective before providing medical corrections.
Directly challenging the patient's beliefs typically increases resistance, whereas empathetic exploration fosters a therapeutic alliance.

Key Concept

In cases of medication nonadherence driven by misinformation, the initial physician response should prioritize validating the patient's positive health intentions and exploring their beliefs without immediate judgment or correction.
Estimated Time:1m 0s
Question 108Question →

A 5555-year-old woman is evaluated in the hospital on postoperative day 66 following an abdominal hysterectomy. She was admitted to the general medical ward and started on an intravenous unfractionated heparin infusion 55 days ago for a right lower extremity deep vein thrombosis. Today, she reports new pain and swelling at the site of a peripheral intravenous catheter in her left arm. Her temperature is 37.2∘C37.2^\circ \text{C} (99.0∘F99.0^\circ \text{F}), blood pressure is 128/82128/82 mmHg, and pulse is 8888/min. Physical examination shows induration, erythema, and tenderness along the left cephalic vein, consistent with superficial thrombophlebitis. There is no active bleeding, and no petechiae are noted.

Laboratory results are as follows:
- Hemoglobin: 12.212.2 g/dL
- Platelet count: 110,000/mm3110,000/\text{mm}^3 (Baseline 55 days ago: 320,000/mm3320,000/\text{mm}^3)
- Partial thromboplastin time (PTT): 6868 seconds

Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Discontinue unfractionated heparin and initiate argatroban

Answer

Discontinue unfractionated heparin and initiate argatroban
The correct action is to discontinue unfractionated heparin and initiate a non-heparin anticoagulant such as argatroban. This patient presents with a classic picture of Type 2 Heparin-Induced Thrombocytopenia (HIT). HIT is an immune-mediated prothrombotic disorder caused by antibodies to platelet factor 4 (PF4) complexed with heparin. Diagnosis requires a high index of clinical suspicion, typically evaluated using the 4T score: Thrombocytopenia (drop >50%>50\%), Timing (onset 5−105-10 days after heparin exposure), Thrombosis (new or progressive), and absence of oTher clear causes. This patient has a severe platelet drop (65%65\% decrease), timing of 55 days, and a new thrombosis (superficial thrombophlebitis), giving her a high probability score. When HIT is strongly suspected, the absolute priority is to immediately stop all heparin products and initiate therapeutic-dose anticoagulation with a non-heparin agent (e.g., argatroban, bivalirudin, or fondaparinux) while awaiting confirmatory testing (PF4 ELISA or serotonin release assay).

Step-by-Step Solution

1
Calculate the 4T score to estimate the clinical probability of Heparin-Induced Thrombocytopenia (HIT).
The patient scores 22 points for thrombocytopenia (>50%>50\% drop), 22 points for timing (day 55), and 22 points for a new thrombosis (superficial thrombophlebitis), yielding a high-probability score of 66.
A >50%>50\% drop in platelets occurring 5−105-10 days after heparin initiation, especially with new thrombosis, is the hallmark presentation of HIT.
2
Evaluate the current treatment regimen based on the clinical diagnosis.
The current unfractionated heparin infusion is actively causing the immune-mediated platelet destruction and hypercoagulable state.
Continuing heparin or delaying its cessation will lead to potentially fatal arterial or venous thromboses.
3
Select the appropriate therapeutic intervention.
Immediate cessation of unfractionated heparin and initiation of a direct thrombin inhibitor (e.g., argatroban) or fondaparinux.
A non-heparin anticoagulant must be started immediately to manage the severe prothrombotic state while awaiting confirmatory laboratory testing.

Key Concept

Monitoring for and managing Heparin-Induced Thrombocytopenia (HIT)
Question 109Question →

During a medication management visit, a 58-year-old woman asks about her current health maintenance requirements. She takes methotrexate and daily prednisone (10 mg10 \text{ mg}) for rheumatoid arthritis, which was diagnosed five years ago. She has never smoked cigarettes. Her body mass index is 21 kg/m221 \text{ kg/m}^2. A review of her preventive care history shows a normal screening colonoscopy three years ago, a negative primary human papillomavirus test two years ago, and a normal bilateral mammogram six months ago. She completed the recombinant zoster and 20-valent pneumococcal conjugate vaccine series last year. Which of the following is the most appropriate indicated preventive service for this patient at this time?

Show answer & explanation

Answer: Dual-energy x-ray absorptiometry

Answer

Dual-energy x-ray absorptiometry
The correct answer is dual-energy x-ray absorptiometry (DEXA) because the United States Preventive Services Task Force (USPSTF) recommends screening for osteoporosis in postmenopausal women younger than 65 years who have an increased risk for osteoporotic fractures. This patient has multiple strong risk factors, including chronic glucocorticoid therapy, rheumatoid arthritis, and a lower BMI. These factors result in a 10-year fracture risk equivalent to or greater than that of a 65-year-old average-risk woman, warranting immediate baseline screening.

Step-by-Step Solution

1
Analyze the patient's demographics and ongoing risk factors.
The patient is a 58-year-old postmenopausal woman with rheumatoid arthritis on chronic glucocorticoids and a BMI of 21 kg/m².
Identifying specific clinical risk factors is necessary to determine if early or accelerated screening is indicated prior to standard age cutoffs.
2
Review the intervals for recently completed screening tests to rule out unnecessary repeat testing.
Colonoscopy was 3 years ago (due in 7 years), primary HPV test was 2 years ago (due in 3 years), and mammogram was 6 months ago (due in 6-18 months). Routine immunizations for high-risk populations (pneumococcal, zoster) are up to date.
Preventing inappropriate interval shortening is a key component of evidence-based preventive care.
3
Evaluate the need for osteoporosis screening based on guidelines.
USPSTF guidelines recommend screening with DEXA for women younger than 65 years who are at increased risk of osteoporosis.
The patient's chronic prednisone use and rheumatoid arthritis diagnosis substantially elevate her fracture risk, making immediate DEXA screening the standard of care.

Key Concept

Osteoporosis screening in high-risk postmenopausal women under age 65
Question 110Question →

During a comprehensive annual evaluation, a 62-year-old man is assessed at the primary care clinic. He has a past medical history of diet-controlled type 2 diabetes mellitus and essential hypertension. His current medications include amlodipine and atorvastatin. He reports feeling well overall, though he notes intermittent, mild lower back pain after heavy yard work; the pain lacks radiation and resolves rapidly with rest and acetaminophen. He denies any bowel or bladder incontinence, saddle anesthesia, or lower extremity weakness.

His substance use history reveals that he began smoking cigarettes at age 20, consuming 1.5 packs daily until he quit on his 50th birthday. He consumes alcohol occasionally but denies illicit drug use. He has been in a monogamous marriage for 35 years.

A review of his preventive health record demonstrates:
- A screening colonoscopy performed 4 years ago at age 58 revealed no polyps or abnormalities.
- Routine screening for HIV, hepatitis B, and hepatitis C conducted at age 55 was negative.
- Following his diabetes diagnosis at age 59, he received a dose of the 20-valent pneumococcal conjugate vaccine (PCV20).
- He completed the two-dose recombinant zoster vaccine series at age 56.
- He received a tetanus, diphtheria, and acellular pertussis (Tdap) booster 3 years ago.
- He received the seasonal influenza vaccine two weeks ago.

Recent laboratory studies from a separate visit two weeks ago show a hemoglobin A1c of 6.2% and an in-range lipid profile. His physical examination today, including a detailed neurologic assessment of the lower extremities, is entirely within normal limits.

Based on current clinical guidelines, which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Annual low-dose computed tomography of the chest

Answer

Annual low-dose computed tomography of the chest
The United States Preventive Services Task Force (USPSTF) recommends annual lung cancer screening with low-dose computed tomography (LDCT) for adults aged 50 to 80 years who have a 20 pack-year smoking history and either currently smoke or have quit within the past 15 years. This patient is 62 years old, has a 45 pack-year smoking history (1.51.5 packs/day ×30\times 30 years), and quit 12 years ago. Therefore, he precisely meets all criteria for annual LDCT screening, which is a strongly indicated Grade B recommendation.

Step-by-Step Solution

1
Calculate the patient's smoking pack-year history and years since quitting.
The patient smoked 1.5 packs per day for 30 years (age 20 to 50), yielding a 45 pack-year history (1.5×30=451.5 \times 30 = 45). He quit 12 years ago.
Lung cancer screening criteria depend precisely on total smoke exposure and the recency of cessation.
2
Evaluate the patient's eligibility for lung cancer screening against current USPSTF guidelines.
The patient meets all criteria: he is within the 50-80 age range (age 62), has ≥20\geq 20 pack-years (45), and quit within the past 15 years (12 years).
Applying the Grade B recommendation for annual low-dose computed tomography (LDCT).
3
Verify if any other preventive services or diagnostic tests take precedence or are co-indicated.
AAA screening is premature (starts at age 65), pneumococcal vaccination is complete (PCV20 is a single-dose regimen), and lumbar MRI is not indicated for mechanical back pain without red flags.
Eliminating distractors based on specific age cutoffs, updated vaccine guidelines, and criteria for resource utilization.

Key Concept

Current clinical guidelines for adult preventive screening and immunizations, focusing on the indication for annual lung cancer screening.
Estimated Time:1m 30s
Question 111Question →

A 62-year-old man comes to the clinic for a routine health maintenance evaluation. He recently went through a divorce and reports being sexually active with multiple new male partners over the past 6 months. He admits to inconsistent condom use. His medical history is significant for essential hypertension, for which he takes amlodipine. He smoked 1.5 packs of cigarettes daily for 20 years but quit 8 years ago. His most recent cancer screening was a colonoscopy at age 54, which was normal. His vaccination history includes the complete hepatitis B series, a tetanus-diphtheria-acellular pertussis (Tdap) booster at age 58, and an influenza vaccine 2 weeks ago. He has never received pneumococcal or zoster vaccines. Vital signs and physical examination are unremarkable. Basic metabolic panel and hepatic function panel are within normal limits. Point-of-care HIV testing is negative, and comprehensive sexually transmitted infection testing is sent to the laboratory. Assuming the pending tests are negative, which of the following is the most appropriate next step in comprehensive preventive care?

Show answer & explanation

Answer: Initiate emtricitabine-tenofovir, order low-dose computed tomography of the chest, and administer recombinant zoster vaccine

Answer

Initiate emtricitabine-tenofovir, order low-dose computed tomography of the chest, and administer recombinant zoster vaccine.
The correct comprehensive preventive care plan for this patient addresses his unique risks across three domains. First, his high-risk sexual behavior warrants the initiation of HIV pre-exposure prophylaxis (PrEP). Second, his smoking history (30 pack-years, quit 8 years ago) and age (62) perfectly align with the USPSTF guidelines for annual lung cancer screening with low-dose computed tomography (LDCT). Finally, all adults aged 50 and older should receive the recombinant zoster vaccine (RZV), making him due for this immunization.

Step-by-Step Solution

1
Evaluate the patient's sexual history and risk for HIV acquisition.
The patient is a man who has sex with men with multiple recent partners and inconsistent condom use.
High-risk sexual behavior is a Grade A USPSTF indication for pre-exposure prophylaxis (PrEP) with emtricitabine-tenofovir.
2
Assess the patient's smoking history against lung and vascular screening guidelines.
The patient has a 30 pack-year history and quit 8 years ago. He is 62 years old.
Patients aged 50-80 with ≥\ge 20 pack-years who currently smoke or quit ≤\le 15 years ago require annual low-dose CT of the chest. He is too young (62) for the AAA ultrasound, which starts at age 65.
3
Determine the appropriate adult immunizations based on age and comorbidities.
The patient is 62 years old and has not received zoster or pneumococcal vaccines.
Recombinant zoster vaccine (RZV) is indicated universally starting at age 50. PCV20 is not indicated for average-risk adults until age 65.
4
Review the colorectal cancer screening history.
Normal colonoscopy at age 54. The patient is now 62.
The standard interval after a normal colonoscopy is 10 years, meaning his next screening is due at age 64. Interval testing with FIT is not indicated.

Key Concept

Simultaneous application of age-appropriate and risk-based preventive care guidelines including HIV PrEP, cancer screening, and adult immunizations.
Question 112Question →

A 31-year-old woman, gravida 1, para 0, presents to the clinic for a routine prenatal visit at 13 weeks of gestation. She has a medical history of chronic hypertension that is currently well controlled. She has never smoked and consumes no alcohol. Her daily medication is nifedipine. Vital signs today demonstrate a blood pressure of 126/82 mm Hg126/82 \text{ mm Hg}, a heart rate of 78/min, and a body mass index of 28 kg/m228 \text{ kg/m}^2. A urine dipstick is negative for protein. Fetal heart tones are audible via Doppler ultrasound. Which of the following is the most appropriate preventive intervention to add to this patient's management plan at this time?

Show answer & explanation

Answer: Initiate low-dose aspirin therapy

Answer

Initiate low-dose aspirin therapy
The correct intervention is to initiate low-dose aspirin therapy. This patient has chronic hypertension, which places her at high risk for developing preeclampsia during pregnancy. The United States Preventive Services Task Force (USPSTF) and the American College of Obstetricians and Gynecologists (ACOG) strongly recommend low-dose aspirin (81 mg/day) prophylaxis starting between 12 and 28 weeks of gestation (optimally before 16 weeks) for women with one or more high-risk factors for preeclampsia. High-risk factors include a history of preeclampsia, multifetal gestation, chronic hypertension, type 1 or 2 diabetes mellitus, renal disease, and autoimmune diseases (such as systemic lupus erythematosus or antiphospholipid syndrome).

Step-by-Step Solution

1
Identify the patient's existing risk factors for obstetric complications.
The patient is nulliparous and has a history of chronic hypertension.
Accurate risk stratification is necessary to determine if targeted preventive measures are indicated during pregnancy.
2
Determine the appropriate preventive guideline for this specific risk profile.
According to the USPSTF, chronic hypertension is designated as a high-risk factor for the development of preeclampsia.
High-risk patients require evidence-based pharmacologic prophylaxis to reduce maternal and fetal morbidity associated with preeclampsia.
3
Select the correct intervention and its appropriate timing.
Low-dose aspirin is recommended to be started after 12 weeks of gestation.
Clinical evidence demonstrates that aspirin safely reduces the incidence of preeclampsia and adverse perinatal outcomes in high-risk populations.

Key Concept

The USPSTF recommends prescribing low-dose aspirin (81 mg/day) as preventive medication after 12 weeks of gestation in pregnant individuals who are at high risk for preeclampsia (e.g., those with chronic hypertension, type 1 or 2 diabetes, or prior preeclampsia).

Alternative Method

Risk assessment for aspirin prophylaxis can also be performed by reviewing moderate risk factors (e.g., nulliparity, obesity with BMI > 30, advanced maternal age > 35, family history of preeclampsia). The presence of multiple moderate risk factors also warrants low-dose aspirin prophylaxis.
Estimated Time:1m 0s
Question 113Question →

Evaluate the following patient profiles during routine ambulatory visits. Match each patient with the most appropriate, guideline-concordant next step in preventive care based on current United States Preventive Services Task Force (USPSTF) and Advisory Committee on Immunization Practices (ACIP) recommendations.

Click a left item, then click its matching right item

Items

A 66-year-old woman who underwent a total hysterectomy for symptomatic uterine leiomyomas five years ago and had three consecutive negative routine Pap tests prior to the surgery.
A 45-year-old man with no chronic medical conditions and a body mass index of 33 kg/m², presenting for his first primary care visit in five years.
A 28-year-old woman at 30 weeks gestation in her first pregnancy, who received a tetanus-diphtheria-acellular pertussis (Tdap) booster at age 24.
A 38-year-old healthy woman whose mother and maternal aunt were both diagnosed with breast cancer in their early 40s.

Matches

Show answer & explanation

Answer

The post-hysterectomy patient requires cessation of cervical screening. The 45-year-old man with obesity requires diabetes screening. The pregnant patient requires Tdap vaccination. The woman with a strong family history of breast cancer requires a familial risk assessment for BRCA.
Each correct match strictly follows current evidence-based guidelines for primary care. Cervical screening is stopped after benign hysterectomy. Diabetes screening starts at age 35 for overweight/obese individuals. Tdap is required in every pregnancy between 27-36 weeks. A strong family history of early breast cancer prompts BRCA risk assessment.

Step-by-Step Solution

1
Analyze the 66-year-old woman's history.
She had a total hysterectomy for a benign indication and no prior high-grade cervical dysplasia.
This confirms she no longer has a cervix and is not at risk for cervical cancer, meaning screening should be discontinued.
2
Analyze the 45-year-old man's demographics and vitals.
He is between the ages of 35 and 70 and has a BMI in the obese range (>30 kg/m²).
Current USPSTF guidelines mandate diabetes screening for overweight or obese adults starting at age 35.
3
Analyze the 28-year-old pregnant woman's vaccination status.
She is at 30 weeks gestation and had a previous Tdap at age 24.
The Tdap vaccine must be given between 27-36 weeks in every pregnancy, making prior non-pregnancy vaccine dates irrelevant.
4
Analyze the 38-year-old woman's family history.
She has multiple first- and second-degree relatives diagnosed with breast cancer before age 50.
This is a red flag for a hereditary cancer syndrome (e.g., BRCA1/2), necessitating formal risk assessment.

Key Concept

Application of age-, sex-, and risk-specific USPSTF and ACIP guidelines for preventive screening and immunizations in adults.
Question 114Question →

An unhoused male patient born in 19681968 presents to a community health outreach clinic to establish primary care. He has not received any medical care in nearly a decade. Medical records indicate a history of chronic hepatitis C virus infection complicated by biopsy-proven cirrhosis; he successfully completed direct-acting antiviral therapy 66 years ago and achieved a sustained virologic response. He reports a history of intravenous substance use, which he also ceased 66 years ago. The patient currently smokes 1.51.5 packs of cigarettes daily, a habit he began at age 1818. His medical history is notable for a severe anaphylactic reaction (hypotension and wheezing) to dietary eggs during childhood. Physical examination reveals scattered spider angiomas but no ascites, jaundice, or encephalopathy. Vital signs are within normal limits. Which of the following preventive health interventions are appropriate for this patient at today's visit? (Select all that apply)

Select all that apply

Show answer & explanation

Answer: Hepatocellular carcinoma surveillance with six-monthly abdominal ultrasonography; Administration of a standard, egg-based inactivated influenza vaccine; Annual lung cancer screening via low-radiation helical chest scanning

Answer

The correct interventions are hepatocellular carcinoma surveillance, administration of an egg-based inactivated influenza vaccine, and annual lung cancer screening.
The correct interventions are based on three distinct guidelines. First, the patient is 5858 years old (2026−19682026 - 1968). According to the American Association for the Study of Liver Diseases (AASLD), patients with established cirrhosis must continue lifelong hepatocellular carcinoma surveillance with abdominal ultrasound every 66 months, even after achieving a sustained virologic response (cure) for hepatitis C. Second, regarding immunizations, the Advisory Committee on Immunization Practices (ACIP) has unequivocally stated that a history of egg allergy (including anaphylaxis) is no longer a contraindication to any influenza vaccine; patients may receive standard egg-based formulations without specialized medical observation. Finally, the patient meets the USPSTF criteria for annual lung cancer screening: he is between 5050 and 8080 years of age, has a smoking history of ≥20\ge 20 pack-years (1.51.5 packs/day ×\times 4040 years = 6060 pack-years), and currently smokes.

Step-by-Step Solution

1
Calculate the patient's age and cumulative smoking history.
The patient is 5858 years old (2026−19682026 - 1968) and has a 6060 pack-year smoking history (1.51.5 packs/day ×\times 4040 years).
Age and pack-years are required to determine eligibility for age-based screenings like lung cancer and abdominal aortic aneurysm (AAA).
2
Evaluate the need for hepatocellular carcinoma (HCC) screening in the context of his liver disease.
HCC screening with an abdominal ultrasound every 66 months is indicated.
Although the hepatitis C virus was cured (sustained virologic response), the pre-existing cirrhosis places him at permanent high risk for HCC.
3
Determine influenza vaccine eligibility given the severe egg allergy.
Standard egg-based influenza vaccine is indicated.
Updated ACIP guidelines state that an egg allergy, even anaphylaxis, is not a contraindication for any influenza vaccine. No special observation is required beyond standard protocols.
4
Assess eligibility for lung cancer screening.
Annual screening with low-dose computed tomography is indicated.
He meets all USPSTF criteria: age 50−8050-80, ≥20\ge 20 pack-year history, and is a current smoker.
5
Evaluate the remaining options (AAA screening and pneumococcal vaccine).
AAA screening is premature, and the sequence for the pneumococcal vaccine is incorrect.
AAA screening starts at age 6565. While pneumococcal vaccination is indicated for cirrhosis, it must be initiated with a conjugate vaccine (PCV20 or PCV15), not PPSV23.

Key Concept

Guideline-concordant preventive care requires synthesizing age, underlying risk factors (e.g., cirrhosis, smoking burden), and updated contraindication guidelines (e.g., removing egg allergy as a barrier to influenza vaccination).
Question 115Question →

A 64-year-old man presents to the emergency department reporting the sudden onset of agonizing, tearing pain in his anterior chest that radiates directly to his mid-back. The pain started abruptly one hour ago while he was eating dinner. His medical history is notable for essential hypertension, obstructive sleep apnea, and hyperlipidemia. The patient appears visibly distressed, agitated, and is sweating profusely. Vital signs demonstrate a temperature of 37.1°C (98.8°F), blood pressure of 220/120 mm Hg in the right arm and 175/95 mm Hg in the left arm, heart rate of 118/min, and respiratory rate of 24/min. Physical examination reveals a new early diastolic decrescendo murmur at the right upper sternal border. Radial pulses are bounding on the right but significantly diminished on the left. Electrocardiography demonstrates sinus tachycardia and criteria for left ventricular hypertrophy, but no acute ST-segment or T-wave changes. Which of the following is the most urgent initial step in the management of this patient?

Show answer & explanation

Answer: Intravenous administration of esmolol

Answer

The most urgent intervention is to administer an intravenous beta-blocker, such as esmolol, to provide immediate anti-impulse therapy.
The patient's classic presentation (abrupt, tearing chest pain, asymmetric blood pressures, pulse deficits, and a murmur of aortic regurgitation) is highly specific for an acute ascending aortic dissection. The immediate priority in initial triage and stabilization is to halt the progression of the dissecting hematoma. The primary drivers of dissection propagation are the absolute blood pressure and the rate of rise of the ventricular driving force (dP/dt). Intravenous beta-blockers, such as esmolol or labetalol, uniquely address both by negatively impacting chronotropy and inotropy. This strictly must be accomplished before diagnostic confirmation is attempted.

Step-by-Step Solution

1
Analyze the clinical presentation
Sudden onset tearing chest pain radiating to the back, asymmetric blood pressures and pulses, and a new diastolic murmur strongly suggest an acute aortic dissection involving the ascending aorta (Stanford Type A).
Recognizing the high-risk features of acute aortic syndrome determines the immediate triage priorities and precludes the misapplication of routine chest pain protocols.
2
Identify the immediate threat to life
The patient's severe hypertension (BP 220/120 mm Hg) and tachycardia generate excessive shear stress (dP/dt) on the aortic wall, risking rapid propagation of the intimal tear, aortic rupture, or tamponade.
In acute dissection, mechanical forces driving blood into the false lumen are the primary determinant of short-term mortality.
3
Select the most urgent stabilization step prior to definitive diagnostic workup
Administer an intravenous beta-adrenergic antagonist (esmolol or labetalol).
Beta-blockade reduces both heart rate and the force of left ventricular ejection (dP/dt), stabilizing the tear. This must be accomplished before sending the patient for computed tomography angiography or utilizing pure vasodilators.

Key Concept

In cases of suspected acute aortic dissection, the most urgent initial stabilization step is aggressive 'anti-impulse' therapy using intravenous beta-blockers to reduce heart rate, blood pressure, and aortic wall shear stress prior to diagnostic imaging.
Question 116Question →

Match each patient's clinical presentation and initial diagnostic findings with the most appropriate next step in their workup sequence.

Click a left item, then click its matching right item

Items

A 26-year-old asymptomatic pregnant woman has a positive rapid plasma reagin (RPR) titer of 1:4 during routine first-trimester prenatal evaluation.
A 54-year-old man with a history of past injection drug use is found to have positive hepatitis C virus (HCV) antibodies on a routine screening panel.
A 32-year-old man undergoes sexually transmitted infection screening and tests reactive on an initial fourth-generation HIV-1/2 antigen/antibody combination assay.
A 38-year-old woman presents with a 6-centimeter expanding annular erythematous rash with central clearing on her thigh after hiking in a wooded area in the Northeast United States.

Matches

Show answer & explanation

Answer

RPR positive in pregnancy pairs with Treponemal-specific assay; HCV antibody positive pairs with Quantitative HCV RNA PCR; Reactive HIV-1/2 antigen/antibody assay pairs with HIV-1/HIV-2 differentiation immunoassay; Erythema migrans rash pairs with no further testing and empiric therapy.
Each correct pairing reflects the standard of care for test sequencing. Syphilis requires treponemal confirmation to rule out biological false positives. Hepatitis C requires RNA testing to differentiate active from resolved infection. HIV requires a differentiation assay to confirm the diagnosis and type the virus. Early localized Lyme disease is a purely clinical diagnosis where further testing is contraindicated due to low sensitivity.

Step-by-Step Solution

1
Analyze each clinical scenario to identify the suspected infectious disease based on the preliminary screening result or physical examination finding.
Identified suspected conditions: syphilis, hepatitis C, HIV, and Lyme disease.
Accurate identification of the underlying condition determines which standardized diagnostic algorithm must be applied.
2
Apply the guideline-directed test sequencing algorithm for each identified condition to determine the specific confirmatory step.
RPR requires treponemal confirmation; HCV antibodies require viral load quantification; initial HIV combination assays require differentiation assays.
Screening tests often have high sensitivity but lower specificity, or they cannot distinguish active from past infection, necessitating specific confirmatory modalities.
3
Recognize conditions where physical findings supersede the need for further sequential laboratory diagnostics.
The erythema migrans rash bypasses the need for serology.
In early localized Lyme disease, clinical diagnosis is highly specific, and antibody tests have poor sensitivity prior to full seroconversion, making further testing unnecessary and potentially misleading.

Key Concept

Standardized diagnostic sequencing algorithms for common infectious diseases
Question 117Question →

A 25-year-old male driver is transported to the trauma bay following a high-speed frontal motor vehicle collision. On arrival, he is unresponsive to verbal stimuli. His breathing is shallow with audible gurgling. Vital signs include a blood pressure of 72/40 mm Hg, pulse of 138/min, and respiratory rate of 8/min. Examination shows extensive maxillofacial ecchymosis and mechanical instability of the pelvic ring. Arrange the following interventions in the most appropriate chronological sequence for this patient's acute management.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence of interventions is: 1) Secure the airway via endotracheal intubation, 2) Apply a pelvic binder and initiate uncrossmatched blood transfusion, 3) Perform a bedside focused assessment with sonography for trauma (FAST), and 4) Transport the patient for a computed tomography (CT) scan.
The Advanced Trauma Life Support (ATLS) protocol dictates a strict sequence of priorities: Airway, Breathing, Circulation, Disability, and Exposure. This patient has immediate airway compromise (gurgling, bradypnea, unresponsiveness) requiring intubation first. Next, profound hemorrhagic shock from suspected pelvic trauma necessitates hemorrhage control (pelvic binder) and volume resuscitation (blood products). Once these immediate, life-saving measures are initiated, a bedside FAST exam acts as an adjunct to identify occult bleeding. Finally, definitive imaging like a CT scan is reserved for patients who have been adequately stabilized, as the radiology suite is unsafe for an actively crashing patient.

Step-by-Step Solution

1
Assess and secure the airway.
The patient is successfully intubated.
The patient has gurgling respirations, a respiratory rate of 8/min, and is unresponsive, indicating an unprotected and inadequate airway. This is the 'A' in the primary survey.
2
Address circulation and active hemorrhage.
A pelvic binder is placed and massive transfusion is initiated.
The patient is in class IV hemorrhagic shock with an unstable pelvis. Early mechanical stabilization and blood products address the 'C' in the primary survey.
3
Utilize bedside diagnostic adjuncts.
A FAST exam is performed without leaving the resuscitation bay.
Once immediate airway and hemodynamic stabilization are underway, a FAST exam rapidly identifies intra-abdominal or pericardial hemorrhage to guide potential surgical intervention.
4
Obtain definitive diagnostic imaging.
The patient is transported to the CT scanner.
Only after the primary survey is complete, immediate life threats are managed, and the patient has achieved a degree of hemodynamic stability, is it safe to leave the resuscitation bay for advanced imaging.

Key Concept

Advanced Trauma Life Support (ATLS) Primary Survey Sequence
Question 118Question →

A 68-year-old man is evaluated on the medical ward for severe right knee pain and swelling that began abruptly overnight. He was admitted 33 days ago for community-acquired pneumonia, which has been improving on empiric intravenous ceftriaxone and oral clarithromycin. His medical history is significant for ischemic cardiomyopathy with a left ventricular ejection fraction of 25%25\%, chronic kidney disease stage 4 (baseline serum creatinine 2.7 mg/dL2.7 \text{ mg/dL}), and poorly controlled type 2 diabetes mellitus.

Current medications include lisinopril, carvedilol, furosemide, dapagliflozin, and insulin glargine.

Vital signs are temperature 37.2∘C37.2^\circ\text{C} (99.0∘F99.0^\circ\text{F}), blood pressure 112/68 mmHg112/68 \text{ mmHg}, pulse 88/min88/\text{min}, and respirations 16/min16/\text{min}.
Physical examination reveals a warm, erythematous, swollen, and exquisitely tender right knee. Range of motion is severely limited by pain. The remainder of the examination is notable for trace bilateral pitting lower extremity edema.

Laboratory studies obtained this morning show:
Blood urea nitrogen: 48 mg/dL48 \text{ mg/dL}
Creatinine: 2.9 mg/dL2.9 \text{ mg/dL}
Glucose, fasting: 285 mg/dL285 \text{ mg/dL}

Right knee arthrocentesis yields 15 mL15 \text{ mL} of cloudy yellow fluid. Synovial fluid analysis shows a leukocyte count of 45,000/μL45,000/\mu\text{L} (85%85\% neutrophils). Polarized light microscopy reveals negatively birefringent, needle-shaped crystals. Gram stain is negative for organisms.

Which of the following is the most appropriate next step in the pharmacologic management of this patient's acute joint condition?

Show answer & explanation

Answer: Intra-articular triamcinolone

Answer

Intra-articular triamcinolone
The correct answer provides targeted, localized treatment (intra-articular triamcinolone) for acute monoarticular gout. This patient has multiple absolute and relative contraindications to standard systemic gout therapies. Nonsteroidal anti-inflammatory drugs (NSAIDs) are contraindicated due to his stage 4 chronic kidney disease and severe heart failure with reduced ejection fraction. Colchicine is strictly contraindicated due to his concurrent use of clarithromycin (a strong CYP3A4 inhibitor), which can cause fatal colchicine toxicity, as well as his advanced renal impairment. Systemic corticosteroids are best avoided due to his poorly controlled type 2 diabetes mellitus (fasting glucose 285 mg/dL285 \text{ mg/dL}). Because the flare is limited to a single large joint (monoarticular), an intra-articular glucocorticoid injection is highly effective and avoids systemic toxicities.

Step-by-Step Solution

1
Diagnose the acute condition based on arthrocentesis.
The presence of negatively birefringent, needle-shaped crystals confirms acute gout. The negative Gram stain and classic presentation rule against septic arthritis.
Establishing the definitive diagnosis guides the targeted pharmacologic intervention.
2
Evaluate the patient's baseline comorbidities for therapeutic contraindications.
The patient has advanced chronic kidney disease (stage 4), severe ischemic cardiomyopathy (HFrEF), and poorly controlled type 2 diabetes mellitus.
Comorbidities eliminate certain first-line gout therapies. NSAIDs are contraindicated in CKD and HFrEF. Systemic steroids are highly risky in severe hyperglycemia.
3
Review the current medication list for dangerous drug-drug interactions.
The patient is taking clarithromycin, a potent CYP3A4 and P-glycoprotein inhibitor.
Clarithromycin combined with colchicine can lead to fatal colchicine toxicity (myelosuppression, neuromyopathy).
4
Select the safest, most effective localized therapy for a single affected joint.
Intra-articular triamcinolone is chosen.
It provides rapid local anti-inflammatory effects while minimizing systemic absorption, thereby safely bypassing the patient's renal, cardiac, and endocrine contraindications.

Key Concept

Pharmacologic management of acute gout in medically complex patients
Question 119Question →

A 6262-year-old man is brought to the emergency department via ambulance due to sudden-onset, severe, tearing chest pain radiating to his interscapular region. The pain began 4545 minutes ago while he was watching television. His past medical history is significant for hypertension, hyperlipidemia, erectile dysfunction, and severe persistent asthma. He was hospitalized two weeks ago for status asthmaticus. His current home medications include amlodipine, atorvastatin, sildenafil as needed, a fluticasone-salmeterol inhaler, and an albuterol rescue inhaler.

On physical examination, the patient appears diaphoretic and in severe distress. Blood pressure is 215/115215/115 mmHg in the right arm and 210/110210/110 mmHg in the left arm. Heart rate is 118118 beats/min, respiratory rate is 2222 breaths/min, and oxygen saturation is 94%94\% on room air. Pulmonary auscultation reveals diffuse bilateral expiratory wheezing.

Laboratory results are as follows:
Sodium: 138138 mEq/L
Potassium: 4.14.1 mEq/L
Chloride: 102102 mEq/L
Calcium: 8.08.0 mg/dL
Albumin: 2.82.8 g/dL
Creatinine: 1.11.1 mg/dL
Troponin I: <0.01< 0.01 ng/mL (Normal: <0.04< 0.04 ng/mL)

A computed tomography (CT) angiography of the chest demonstrates an intimal flap in the descending thoracic aorta, distal to the origin of the left subclavian artery.

Which of the following is the most appropriate initial pharmacologic intervention for this patient?

Show answer & explanation

Answer: Intravenous diltiazem

Answer

Intravenous diltiazem
The correct answer is intravenous diltiazem. The primary initial goal in managing an acute aortic dissection is to reduce aortic wall shear stress (dP/dt) by rapidly lowering the heart rate to 6060 beats/min or less and systolic blood pressure to 120120 mmHg or less. Intravenous beta-blockers are the standard first-line therapy. However, this patient presents with diffuse expiratory wheezing and a history of recent status asthmaticus, making beta-blockers strictly contraindicated due to the high risk of precipitating fatal bronchospasm. In such clinical scenarios, intravenous non-dihydropyridine calcium channel blockers, such as diltiazem or verapamil, are the preferred alternative agents. They safely and effectively provide the necessary negative chronotropic and inotropic effects to stabilize the aorta without exacerbating reactive airway disease.

Step-by-Step Solution

1
Diagnose the primary life-threatening condition based on imaging.
The CT angiography confirms an acute Type B aortic dissection.
Accurate diagnosis is required to establish the immediate hemodynamic goals: rapidly lowering heart rate and blood pressure to reduce aortic wall shear stress (dP/dt).
2
Identify the standard first-line pharmacologic treatment and evaluate for patient-specific contraindications.
Intravenous beta-blockers (e.g., labetalol, esmolol) are standard. However, this patient's diffuse bilateral wheezing indicates severe active asthma, an absolute contraindication to non-selective beta-blockade.
Administering a beta-blocker to a patient in an active asthma exacerbation can precipitate fatal bronchospasm.
3
Select the appropriate alternative medication to achieve the hemodynamic goals.
Intravenous diltiazem (a non-dihydropyridine calcium channel blocker) is selected.
Diltiazem provides the necessary negative chronotropic and inotropic effects to reduce dP/dt safely in patients who cannot tolerate beta-blockers.
4
Rule out distracting laboratory abnormalities and drug interactions.
The patient's hypocalcemia is a harmless artifact (pseudohypocalcemia) due to hypoalbuminemia. Nitroglycerin cannot be used due to his recent sildenafil use.
Avoiding unnecessary treatments and preventing fatal drug-drug interactions (nitrates + PDE5 inhibitors) is critical in emergency management.

Key Concept

In acute aortic dissection, initial management requires rapid reduction of heart rate and blood pressure to decrease aortic wall stress; while intravenous beta-blockers are first-line, intravenous non-dihydropyridine calcium channel blockers (diltiazem or verapamil) are the preferred alternative in patients with absolute contraindications such as severe active asthma.
Question 120Question →

A 71-year-old woman with widely metastatic breast cancer is admitted to the inpatient hospice unit for end-of-life care. She is actively dying and minimally responsive. Over the past 24 hours, she has experienced episodes of severe terminal delirium with agitation, which are currently being managed with scheduled haloperidol. Her family is now highly distressed by loud, gurgling respiratory sounds originating from her upper airway. Auscultation reveals coarse upper airway transmitted sounds with clear lung bases. Her respiratory rate is 14/min, and she shows no signs of air hunger, accessory muscle use, or labored breathing during quiet intervals. Which of the following is the most appropriate next step in the management of this patient's respiratory symptom?

Show answer & explanation

Answer: Administer intravenous glycopyrrolate

Answer

Administer intravenous glycopyrrolate
The correct answer involves administering an anticholinergic medication that minimizes central nervous system side effects. Glycopyrrolate is a quaternary ammonium compound that is highly polar and therefore does not cross the blood-brain barrier. It effectively dries oropharyngeal secretions (resolving the 'death rattle') without risking the exacerbation of the patient's severe terminal delirium.

Step-by-Step Solution

1
Identify the primary clinical symptom causing distress.
The patient has loud, gurgling upper airway noises, commonly known as a 'death rattle', caused by pooled oropharyngeal secretions in a dying patient who can no longer clear them.
Accurate symptom identification directs the choice of pharmacologic or non-pharmacologic intervention.
2
Evaluate the patient's concurrent conditions and clinical context.
The patient is actively dying and suffers from severe terminal delirium with agitation.
Concurrent conditions dictate which medications are safe and which are contraindicated based on side effect profiles.
3
Select the appropriate pharmacologic therapy while avoiding contraindications.
An anticholinergic agent is needed to dry secretions. Glycopyrrolate is selected because it is a quaternary amine that does not cross the blood-brain barrier.
Alternative anticholinergics like scopolamine or atropine are tertiary amines that penetrate the central nervous system and can severely exacerbate the patient's terminal delirium.

Key Concept

Management of terminal secretions ('death rattle') in the setting of concurrent terminal delirium requires quaternary amine anticholinergics (e.g., glycopyrrolate) that do not cross the blood-brain barrier.
PreviousPage 6 / 104Next
Patient Management Practice Questions — USMLE Step 3 — Page 6 | Examkin